HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NAD Head Laura Brett On Program Streamlining, Class Action Climate And Mascara Feuds

This article was originally published in The Rose Sheet

Executive Summary

A Q&A with Laura Brett, four months into her new role as director of the National Advertising Division.

You may also be interested in...



That Was Fast! ‘30 Minute’ Claim On Lumineux Whitening Strips Goes From NAD Forum To Federal Court

The National Advertising Division recommended in November that Oral Essentials, Inc. discontinue or modify its “30 minutes to whiter teeth” claim on Lumineux Whitening Strips to avoid implying that a single application will do the deed. Now the company is being targeted with a putative class action in New York’s Eastern District alleging false and misleading advertising.

Young Living’s ‘Therapeutic’ Essential Oil Claims Are False Advertising – Proposed US Class Action

The Lehi, Utah-based MLM firm deceives consumers with its “therapeutic-grade” product labeling and claims linking its essential oils to stress relief, mood enhancement and sleep benefits, according to a class action complaint filed in New York federal court.

Too Faced To Appeal NAD Ruling On '1,944% More Volume' Mascara Claim

The National Advertising Division sides with challenger Benefit Cosmetics, advising Lauder's Too Faced brand to discontinue claims that its Better Than Sex mascara awards “1,944% more volume." Too Faced is appealing the decision, which raises questions about evidentiary thresholds and confidentiality protections.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS121338

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel